Clinical Characteristics and Outcomes in NSCLC Patients Associated with Very High PD-L1 Expression

被引：0
|
作者：
Mcloughlin, E. [1 ]
Hanson, L. [2 ]
Moore, M. [3 ]
Horton, B. [4 ]
Gentzler, R. [1 ]
Hall, R. [1 ]
机构：
[1] Univ Virginia, Div Hematol Oncol, Charlottesville, VA USA
[2] Univ Virginia, Med, Charlottesville, AL USA
[3] Univ Virginia, Sch Med, Charlottesville, AL USA
[4] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Div Translat Res & Appl Stat, Charlottesville, AL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Non-Small Cell Lung Cancer; metastatic;
D O I：
10.1016/j.jtho.2019.08.1395
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-52
引用
收藏
页码：S659 / S660
页数：2
相关论文
共 50 条
  • [41] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kojima, Kensuke
    Sakamoto, Tetsuki
    Kasai, Takahiko
    Kagawa, Tomoko
    Yoon, Hyungeun
    Atagi, Shinji
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [42] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kensuke Kojima
    Tetsuki Sakamoto
    Takahiko Kasai
    Tomoko Kagawa
    Hyungeun Yoon
    Shinji Atagi
    Scientific Reports, 11
  • [43] PD-L1 expression and efficacy of pembrolizumab as monotherapy in NSCLC
    Jorgensen, Jan Trost
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [44] Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC
    Bassanelli, Maria
    Sioletic, Stefano
    Martini, Maurizio
    Giacinti, Silvana
    Viterbo, Antonella
    Staddon, Anita
    Liberati, Fabrizio
    Ceribelli, Anna
    ANTICANCER RESEARCH, 2018, 38 (07) : 3789 - 3796
  • [45] Clinicopathologic values of PD-L1 expression and polymorphism in NSCLC
    Kim, K. -H.
    VIRCHOWS ARCHIV, 2017, 471 : S110 - S111
  • [46] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    LABORATORY INVESTIGATION, 2018, 98 : 755 - 755
  • [47] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    MODERN PATHOLOGY, 2018, 31 : 755 - 755
  • [48] PD-L1 expression in NSCLC - our institution experience
    Krajnovic, B.
    Sekerus, V.
    Stojanovic, G.
    Zaric, B.
    Lazin, S.
    Lovrenski, A.
    Maksimovic, S.
    Tegeltija, D.
    VIRCHOWS ARCHIV, 2021, 479 : S161 - S161
  • [49] Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
    Kim A. Brogden
    Deepak Parashar
    Andrea R. Hallier
    Terry Braun
    Fang Qian
    Naiyer A. Rizvi
    Aaron D. Bossler
    Mohammed M. Milhem
    Timothy A. Chan
    Taher Abbasi
    Shireen Vali
    BMC Cancer, 18
  • [50] Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
    Brogden, Kim A.
    Parashar, Deepak
    Hallier, Andrea R.
    Braun, Terry
    Qian, Fang
    Rizvi, Naiyer A.
    Bossler, Aaron D.
    Milhem, Mohammed M.
    Chan, Timothy A.
    Abbasi, Taher
    Vali, Shireen
    BMC CANCER, 2018, 18
12345